• Newsroom»
  • Alerts»
  • President Signs Law Reauthorizing Drug and Device User...

Alert

Recommended Alerts

Sign Up For Alerts

A new dawn for regulation of medical technologies in the UK post-Brexit? From European directives to the proposed stand-alone regulatory regime for the future

Last month the Medicines and Healthcare products Regulatory Agency launched a public consultation on the future of medical device regulation in the UK.

Read More

President Signs Law Reauthorizing Drug and Device User Fees: Legislation Contains Several Important FDA Reforms

Practices: Life Sciences, FDA Regulatory, Advertising & Promotion, Congressional Investigations & Public Policy, Due Diligence Reviews & Transactional Support, FDA Enforcement Actions & Litigation, Post-Approval Compliance, Regulatory Strategy, Product Development & Product Approvals Industries: Biotechnology & Pharmaceuticals

Printer-Friendly Version

Cookie Settings